亚洲 · 综合新闻 · New Straits Times
Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil
详细摘要
Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nst.com.my)





